Two-unit Cantilever Implant Prostheses Made of Monolithic Zirconia or PFM
Launched by UNIVERSITY OF GENEVA, SWITZERLAND · Jan 13, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of dental prosthetics, which are artificial teeth supported by implants. The goal is to see how well these prosthetics last and how they perform over time. One type is made from a strong material called monolithic zirconia, while the other is made from porcelain fused to metal. Researchers want to understand if the type of material affects the success of the dental work, as well as other factors like wear and patient satisfaction.
To participate in this trial, you need to be at least 22 years old and have good oral health. You should have a gap between two teeth in the back of your mouth where dental implants can be placed. However, if you have severe teeth grinding habits, poor oral hygiene, or are pregnant, you won’t be eligible. Participants will receive either type of prosthetic and will be monitored for their performance over time. This study aims to help improve dental treatments for people with missing teeth and provide valuable information for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimal age of 22 years old.
- • No general medical condition which represents a contraindication to implant treatment
- • Good oral hygiene (PII ≤ 20%), and healthy periodontal tissues (BOP≤ 20%)
- • Two adjacent-teeth gap in posterior maxilla or mandible arch (first premolar, second premolar, first molar, second molar) with an osseointegrated regular or wide-diameter bone-level implant in a prosthetically correct position to allow occlusal screw-retention. Free-end edentulous gaps can also be included
- • Presence of antagonist occlusal units
- Exclusion Criteria:
- • Severe bruxism or clenching habits
- • Patients with inadequate oral hygiene or persistent intraoral infection
- • Women who are pregnant or breast feeding at the day of inclusion
- • Smokers exceeding 15 cigarettes / day, or equivalent; patients chewing tobacco
- • Unable or unwilling to cooperate for the trial period
- • Estimated cantilever crown mesial-distal length \> 10 mm
- • Estimated implant crown height (from implant platform to occlusal contact points) \> 15 mm
About University Of Geneva, Switzerland
The University of Geneva, located in Switzerland, is a prestigious research institution renowned for its commitment to advancing scientific knowledge and improving public health. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at exploring innovative therapies and enhancing patient care. Its dedicated research teams, equipped with state-of-the-art facilities and a robust ethical framework, strive to translate scientific discoveries into practical applications, ultimately contributing to the global advancement of medical science and the well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
Patients applied
Trial Officials
João Pitta, Dr
Principal Investigator
University of Geneva
Irena Sailer, Prof
Study Chair
University of Geneva
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials